Taylor Schreiber
Founder at SHATTUCK LABS, INC.
Net worth: 25 M $ as of 31/03/2024
Profile
Taylor H.
Schreiber is the founder.
He founded Shattuck Labs, Inc. in 2016 and currently holds the title of Chief Executive Officer & Director.
He also held the position of Director at Pelican Therapeutics, Inc. from 2011 to 2017.
Additionally, he served as the Chief Scientific Officer at Scorpius Holdings, Inc. from 2015 to 2016.
Dr. Schreiber has an undergraduate degree from Bucknell University and a doctorate from The University of Miami Leonard M.
Miller School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SHATTUCK LABS, INC.
5.81% | 12/01/2024 | 2,757,686 ( 5.81% ) | 25 M $ | 31/03/2024 |
Taylor Schreiber active positions
| Companies | Position | Start |
|---|---|---|
| SHATTUCK LABS, INC. | Founder | 01/01/2016 |
Former positions of Taylor Schreiber
| Companies | Position | End |
|---|---|---|
Pelican Therapeutics, Inc.
 Pelican Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Pelican Therapeutics, Inc. operates as an immuno-oncology company. It develops biological agents that represents the next generation of tumor necrosis factor (TNF) based immunotherapy. The company was founded by Jeffrey Wolf and Josiah C. Hornblower on March 6, 2017 and is headquartered in Dallas, TX. | Director/Board Member | 01/01/2017 |
| SCORPIUS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 31/12/2016 |
| SCORPIUS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Taylor Schreiber
| Bucknell University | Undergraduate Degree |
| The University of Miami Leonard M. Miller School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SCORPIUS HOLDINGS, INC. | Health Technology |
| SHATTUCK LABS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Pelican Therapeutics, Inc.
Pelican Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Pelican Therapeutics, Inc. operates as an immuno-oncology company. It develops biological agents that represents the next generation of tumor necrosis factor (TNF) based immunotherapy. The company was founded by Jeffrey Wolf and Josiah C. Hornblower on March 6, 2017 and is headquartered in Dallas, TX. | Health Services |
- Stock Market
- Insiders
- Taylor Schreiber
